{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:42:21Z","timestamp":1793900541592,"version":"4.8.0"},"reference-count":49,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"AptamiR Therapeutics, Inc."}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Diab Res Care"],"accepted":{"date-parts":[[2020,8,13]]},"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n                  <jats:title>Introduction<\/jats:title>\n                  <jats:p>We previously demonstrated in primary cultures of human subcutaneous adipocytes and in a mouse model of diet-induced obesity that specific microRNA-22-3p antagomirs produce a significant reduction of fat mass and an improvement of several metabolic parameters. These effects are related to the activation of target genes such as <jats:italic>KDM3A<\/jats:italic>, <jats:italic>KDM6B<\/jats:italic>, <jats:italic>PPARA<\/jats:italic>, <jats:italic>PPARGC1B<\/jats:italic> and <jats:italic>SIRT1<\/jats:italic> involved in lipid catabolism, thermogenesis, insulin sensitivity and glucose homeostasis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research design and methods<\/jats:title>\n                  <jats:p>We now report a dedicated study exploring over the course of 3 months the metabolic and energetic effects of subcutaneous administration of our first miR-22-3p antagomir drug candidate (APT-110) in adult C57BL\/6 male mice. Body composition, various blood parameters and energy expenditure were measured at several timepoints between week 12 and week 27 of age.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Weekly subcutaneous injections of APT-110 for 12 weeks produced a sustained increase of energy expenditure as early as day 11 of treatment, a significant fat mass reduction, but no change of appetite nor physical activity. Insulin sensitivity as well as circulating glucose, cholesterol and leptin were improved. There was a dramatic reduction of liver steatosis after 3 months of active treatment. RNA sequencing revealed an activation of lipid metabolism pathways in a tissue-specific manner.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>These original findings suggest that microRNA-22-3p inhibition could lead to a potent treatment of fat accumulation, insulin resistance, and related complex metabolic disorders such as obesity, type 2 diabetes mellitus and non-alcoholic fatty liver disease.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1136\/bmjdrc-2020-001478","type":"journal-article","created":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T11:49:29Z","timestamp":1601552969000},"page":"e001478","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":39,"title":["Metabolic and energetic benefits of microRNA-22 inhibition"],"prefix":"10.1136","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4546-180X","authenticated-orcid":false,"given":"Marc","family":"Thibonnier","sequence":"first","affiliation":[{"name":"R&D, AptamiR Therapeutics, Inc, Naples, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Esau","sequence":"additional","affiliation":[{"name":"R&D, AptamiR Therapeutics, Inc, Naples, Florida, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujoy","family":"Ghosh","sequence":"additional","affiliation":[{"name":"Centre for Computational Biology and Program in Cardiovascular & Metabolic Disorders, Duke-NUS Medical School, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Wargent","sequence":"additional","affiliation":[{"name":"Clore Laboratory, University of Buckingham, Buckingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Stocker","sequence":"additional","affiliation":[{"name":"Clore Laboratory, University of Buckingham, Buckingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,1]]},"reference":[{"key":"2025073112362496000_8.1.e001478.1","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jval.2016.02.008","article-title":"Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis","volume":"19","author":"Kim","year":"2016","journal-title":"Value Health"},{"key":"2025073112362496000_8.1.e001478.2","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2019.107473","article-title":"When should fixed ratio basal insulin\/glucagon-like peptide-1 receptor agonists combination products be considered?","volume":"33","author":"David","year":"2019","journal-title":"J Diabetes Complications"},{"key":"2025073112362496000_8.1.e001478.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2018.01.001"},{"key":"2025073112362496000_8.1.e001478.4","doi-asserted-by":"publisher","DOI":"10.4093\/dmj.2016.40.1.12"},{"key":"2025073112362496000_8.1.e001478.5","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/j.2040-4603.2017.tb00784.x","article-title":"Brown and beige adipose tissues in health and disease","volume":"7","author":"Rui","year":"2017","journal-title":"Compr Physiol"},{"key":"2025073112362496000_8.1.e001478.6","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201100899"},{"key":"2025073112362496000_8.1.e001478.7","doi-asserted-by":"crossref","first-page":"88517","DOI":"10.18632\/oncotarget.19774","article-title":"Microrna deregulation in nonalcoholic steatohepatitis-associated liver carcinogenesis","volume":"8","author":"de Conti","year":"2017","journal-title":"Oncotarget"},{"key":"2025073112362496000_8.1.e001478.8","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-2007-1"},{"key":"2025073112362496000_8.1.e001478.9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-28854-4","article-title":"Non-Invasive prediction of NAFLD severity: a comprehensive, independent validation of previously postulated serum microRNA biomarkers","volume":"8","author":"L\u00f3pez-Riera","year":"2018","journal-title":"Sci Rep"},{"key":"2025073112362496000_8.1.e001478.10","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2868"},{"key":"2025073112362496000_8.1.e001478.11","doi-asserted-by":"crossref","first-page":"19290","DOI":"10.1002\/jcb.29299","article-title":"The role of microRNAs in the regulation of insulin signaling pathway with respect to metabolic and mitogenic cascades: a review","volume":"120","author":"Ebrahimi","year":"2019","journal-title":"J Cell Biochem"},{"key":"2025073112362496000_8.1.e001478.12","doi-asserted-by":"crossref","first-page":"H291","DOI":"10.1152\/ajpheart.00691.2017","article-title":"Micrornas as regulators of mitochondrial dysfunction and obesity","volume":"315","author":"Murri","year":"2018","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2025073112362496000_8.1.e001478.13","doi-asserted-by":"crossref","DOI":"10.3390\/cells8121552","article-title":"Towards a better understanding of beige adipocyte plasticity","volume":"8","author":"Paulo","year":"2019","journal-title":"Cells"},{"key":"2025073112362496000_8.1.e001478.14","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1089\/nat.2019.0820","article-title":"Metabolic benefits of microRNA-22 inhibition","volume":"30","author":"Thibonnier","year":"2020","journal-title":"Nucleic Acid Ther"},{"key":"2025073112362496000_8.1.e001478.15","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00676.2006"},{"key":"2025073112362496000_8.1.e001478.16","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2013.00064","article-title":"Detection of thermogenesis in rodents in response to anti-obesity drugs and genetic modification","volume":"4","author":"Arch","year":"2013","journal-title":"Front Physiol"},{"key":"2025073112362496000_8.1.e001478.17","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-128"},{"key":"2025073112362496000_8.1.e001478.18","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3167-5_3"},{"key":"2025073112362496000_8.1.e001478.19","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1064."},{"key":"2025073112362496000_8.1.e001478.20","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tem.2015.03.003","article-title":"Physiology and relevance of human adaptive thermogenesis response","volume":"26","author":"Celi","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"2025073112362496000_8.1.e001478.21","doi-asserted-by":"publisher","DOI":"10.1210\/er.2012-1081"},{"key":"2025073112362496000_8.1.e001478.22","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2014.952328"},{"key":"2025073112362496000_8.1.e001478.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2013.04.017"},{"key":"2025073112362496000_8.1.e001478.24","first-page":"2104","article-title":"miRNA regulation of white and brown adipose tissue differentiation and function","volume":"2016","author":"Price","year":"1861","journal-title":"Biochim Biophys Acta"},{"key":"2025073112362496000_8.1.e001478.25","doi-asserted-by":"publisher","DOI":"10.1517\/14728220903190707"},{"key":"2025073112362496000_8.1.e001478.26","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.25"},{"key":"2025073112362496000_8.1.e001478.27","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.abb.2015.09.018","article-title":"MicroRNAs in obesity-associated disorders","volume":"589","author":"Abente","year":"2016","journal-title":"Arch Biochem Biophys"},{"key":"2025073112362496000_8.1.e001478.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3510-2"},{"key":"2025073112362496000_8.1.e001478.29","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2014.29.2.122"},{"key":"2025073112362496000_8.1.e001478.30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ijo.2012.59","article-title":"MicroRNAs in adipose tissue: their role in adipogenesis and obesity","volume":"37","author":"Hilton","year":"2013","journal-title":"Int J Obes"},{"key":"2025073112362496000_8.1.e001478.31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-8-166"},{"key":"2025073112362496000_8.1.e001478.32","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-016-1446-8"},{"key":"2025073112362496000_8.1.e001478.33","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.cell.2017.08.035","article-title":"Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin Sensitivity","volume":"171","author":"Ying","year":"2017","journal-title":"Cell"},{"key":"2025073112362496000_8.1.e001478.34","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1808855115"},{"key":"2025073112362496000_8.1.e001478.35","doi-asserted-by":"publisher","DOI":"10.1038\/nature21365"},{"key":"2025073112362496000_8.1.e001478.36","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3390\/jcm8060854","article-title":"Adipose tissue-derived signatures for obesity and type 2 diabetes: adipokines, Batokines and microRNAs","volume":"8","author":"Lee","year":"2019","journal-title":"J Clin Med"},{"key":"2025073112362496000_8.1.e001478.37","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1042\/CS20171368","article-title":"Loss of microRNA-22 prevents high-fat diet induced dyslipidemia and increases energy expenditure without affecting cardiac hypertrophy","volume":"131","author":"Diniz","year":"2017","journal-title":"Clin Sci"},{"key":"2025073112362496000_8.1.e001478.38","doi-asserted-by":"publisher","DOI":"10.15252\/embj.201695988"},{"key":"2025073112362496000_8.1.e001478.39","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1924"},{"key":"2025073112362496000_8.1.e001478.40","doi-asserted-by":"publisher","DOI":"10.1039\/c1mb05041a"},{"key":"2025073112362496000_8.1.e001478.41","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0075882"},{"key":"2025073112362496000_8.1.e001478.42","doi-asserted-by":"crossref","first-page":"100093","DOI":"10.1016\/j.jhepr.2020.100093","article-title":"miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction","volume":"2","author":"Hu","year":"2020","journal-title":"JHEP Rep"},{"key":"2025073112362496000_8.1.e001478.43","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.1093\/nar\/gkx605","article-title":"Combinatorial ensemble miRNA target prediction of co-regulation networks with non-prediction data","volume":"45","author":"Davis","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"2025073112362496000_8.1.e001478.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2009.05.001"},{"key":"2025073112362496000_8.1.e001478.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2011.12.018"},{"key":"2025073112362496000_8.1.e001478.46","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2391"},{"key":"2025073112362496000_8.1.e001478.47","doi-asserted-by":"crossref","DOI":"10.1186\/s40169-017-0181-2","article-title":"A perspective on multi-target drug discovery and design for complex diseases","volume":"7","author":"Ramsay","year":"2018","journal-title":"Clin Transl Med"},{"key":"2025073112362496000_8.1.e001478.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.11.044"},{"key":"2025073112362496000_8.1.e001478.49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1179551420905844","article-title":"Multiagonist unimolecular peptides for obesity and type 2 diabetes: current advances and future directions","volume":"13","author":"Hasib","year":"2020","journal-title":"Clin Med Insights Endocrinol Diabetes"}],"container-title":["BMJ Open Diabetes Research &amp; Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjdrc-2020-001478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,31]],"date-time":"2025-07-31T19:36:36Z","timestamp":1753990596000},"score":1,"resource":{"primary":{"URL":"https:\/\/drc.bmj.com\/lookup\/doi\/10.1136\/bmjdrc-2020-001478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,10,1]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/bmjdrc-2020-001478"],"URL":"https:\/\/doi.org\/10.1136\/bmjdrc-2020-001478","relation":{},"ISSN":["2052-4897"],"issn-type":[{"value":"2052-4897","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}